Walleye Capital LLC Seagen Inc. Transaction History

Walleye Capital LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$191.51 - $216.16 $40.2 Million - $45.4 Million	210,015 Added 1305.09%	226,107 $48 Million
Q2 2023 Aug 14, 2023	BUY	$187.64 - $206.25 $2.5 Million - $2.74 Million	13,305 Added 477.4%	16,092 $3.1 Million
Q1 2023 May 15, 2023	SELL	$127.59 - $203.08 $8.79 Million - $14 Million	-68,912 Reduced 96.11%	2,787 $564,000
Q4 2022 Feb 14, 2023	BUY	$117.37 - $139.17 $8.42 Million - $9.98 Million	71,699 New	71,699 $9.21 Million
Q2 2022 Aug 08, 2022	SELL	$108.81 - $179.33 $2.7 Million - $4.46 Million	-24,856 Reduced 90.53%	2,600 $460,000
Q1 2022 May 16, 2022	SELL	$119.61 - $157.85 $1.43 Million - $1.88 Million	-11,917 Reduced 30.27%	27,456 $3.96 Million
Q4 2021 Mar 03, 2022	BUY	$142.57 - $190.86 $5.61 Million - $7.51 Million	39,373 New	39,373 $6.09 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.